Background. A cluster of proinflammatory cytokines plays an important role in the development of various renal diseases, and the expression of these cytokines is genetically modified. To examine the association between polymorphisms of proinflammatory cytokine genes and albuminuria, a cross-sectional study was conducted in the general population. Methods. Single nucleotide polymorphisms (SNPs) in six proinflammatory cytokine genes, including interleukin (IL)-1b, IL-6, IL-8, tumor necrosis factor (TNF)-a, CC chemokine ligand 1 (CCL1) and monocyte chemoattractant protein-1 (MCP-1), were genotyped in 2927 Japanese subjects. Urine albumin-creatinine ratio (UACR) was measured in morning spot urine samples. Results. Albuminuria (UACR ! 30 mg/g) was significantly associated with the A/A 1 A/G genotype at rs2069852 in the IL-6 gene (P ¼ 0.01) and the A/A genotype at rs228269 in the CCL1 gene (P ¼ 0.002). Multivariate analysis with adjustment for traditional risk factors showed that these genotypes independently predicted albuminuria [odds ratio (OR) 1.782, 95% confidence interval (CI) 1.171-2.712, P ¼ 0.007 for the A/A 1 A/G genotype at rs2069852 in IL-6, and OR 1.432, 95% CI 1.128-1.770, P ¼ 0.003 for the A/A genotype at rs228269 in CCL1]. The prevalence of albuminuria and the UACR were increased along with the increase of risk genotypes.
Introduction
Albuminuria reflects an injury to the glomerular vasculature and is associated with a high risk of cardiovascular and allcause mortality. Previous epidemiological studies have documented environmental factors, including hypertension, diabetes and metabolic syndrome, as increasing the risk for development of albuminuria [1] . In addition to these environmental factors, genetic factors may also be involved in the development of albuminuria [2] . Extensive research focusing on genetic influences on albuminuria has been conducted in patients with diabetic nephropathy [3] . The possible involvement of several genes, including the solute carrier family 12 (sodium/chloride transporters) member 3 (SLC12A3) [4] , engulfment and cell motility 1 (ELMO1) [5] , CC chemokine ligand (CCL) 5 [6] and interleukin (IL)-6 [7] , have been reported. However, the association between genetic factors and albuminuria in the general population is largely unknown.
Experimental studies have shown that proinflammatory cytokines such as IL-1, tumor necrosis factor-a (TNF-a) and monocyte chemoattractant protein-1 (MCP-1)/CCL2 participate in the process of renal injury [8] . The expression of these cytokines in human renal biopsy specimens was regarded as confirmation of some types of chronic kidney disease [8, 9] and it has been proposed that a cluster of proinflammatory cytokines might be involved in renal injury.
Based on these observations, we hypothesized that genetic factors influencing inflammatory responses may affect the development of albuminuria. In order to clarify this, the association between proinflammatory cytokine genotypes and albuminuria was examined in the general population.
(COE) Program and Global COE in Japan, as described in detail previously [10] . This study was a baseline survey consisting of a self-administered questionnaire on lifestyle, blood pressure measurements, anthropometric measurements and collection of blood and urine specimens from participants at annual health checkups. Genomic DNA was extracted from peripheral blood samples as previously described [10] .
The subjects surveyed in this study were the general population !40 years of age in Takahata, Japan. In 2004 and 2005, a total of 3115 subjects (mean age 63 years; 1380 males, 1735 females) took part in the program and agreed to participate in the study. Of these 3115 subjects, 188 were excluded from the present analysis due to incomplete data. Therefore, data from 2927 subjects were used in the final analyses (mean age 63 years; 1332 males, 1595 females). The study was approved by the institutional ethics committee and all participants gave written informed consent.
Clinical assessments
Information concerning medical history, current medications, smoking habits and alcohol intake was obtained from a self-reported questionnaire. Blood pressures were determined using a mercury manometer, with subjects resting in a seated position for at least 5 min before measurement. Hypertension was defined as a systolic blood pressure !140 mm Hg and/or diastolic blood pressure !90 mm Hg and/or the use of antihypertensive medication. Body mass index was calculated as weight (kilogram) divided by height (square meter). Obesity was specified as a body mass index !25.0 kg/m 2 for both men and women. A diagnosis of diabetes was ascertained either by self-report or by a fasting blood sugar measurement !126 mg/dL or glycated hemoglobin (HbA1c) !6.5%. Hypercholesterolemia was defined as serum total cholesterol !220 mg/dL and/or the use of antihyperlipidemic medication. Serum high-sensitivity C-reactive protein (hsCRP) was assessed using the latex agglutination method. Urine albumin-creatinine ratio (UACR) was calculated by analysis of a single spot urine specimen collected in the morning. Urinary albumin concentration was determined by immunoturbidimetry. Albuminuria was defined as UACR ! 30 mg/g and included microalbuminuria (30 mg/g UACR < 300 mg/g) and macroalbuminuria (UACR ! 300 mg/g). A UACR <30 mg/g was defined as normoalbuminuria [11] . Serum creatinine was measured by the enzymatic method and glomerular filtration rate was estimated using the Japanese version of the modified MDRD equation [12] .
Selection and genotyping of single-nucleotide polymorphisms
The dbSNP database of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/SNP/) and the International HapMap Project (http://www.hapmap.org/index.html) were used to identify single-nucleotide polymorphisms (SNPs) in six proinflammatory cytokine genes (IL-1b, IL-6, IL-8, TNF-a, CCL1 and MCP-1/CCL2) with minor allele frequencies >0.1 in the Japanese general population. Based on previous studies in renal and other inflammatory diseases, we selected one common SNP that is associated with the function of each candidate gene (rs1143627 in the IL-1b promoter, rs2069852 in 3# near gene region of IL-6, rs4073 in the IL-8 promoter, rs1799724 in the TNF-a promoter, rs2282691 in the CCL1 enhancer and rs1024611 in the MCP-1/CCL2 promoter) and genotyped. All SNPs used in this study gave accurate typing (call rate > 99%).
Genotyping was performed as described previously [13] . Briefly, genotypes for these six SNPs were determined by Invader assay and TaqMan allelic discrimination assay. Reagents were purchased from Applied Biosystems (Foster City, CA). TaqMan probes were designed and synthesized by Applied Biosystems and distinguished the SNPs after polymerase chain reaction (PCR) amplification. One allelic probe was labeled with the fluorescent FAM dye and the other with the fluorescent VIC dye. PCR was performed using TaqMan Universal Master Mix without UNG (Applied Biosystems) with PCR primers at a concentration of 900 nM and TaqMan MGB probes at a concentration of 200 nM. Reactions were performed in 384-well format in a total reaction volume of 3 lL using 3 ng of genomic DNA. The plates were placed in a GeneAmp PCR System 9700 (Applied Biosystems) and heated at 95°C for 10 min, followed by 40 cycles of 92°C for 15 s and 60°C for 1 min, with a final incubation at 25°C. The plates were read on a Prism 7900HT instrument (Applied Biosystems) to determine the fluorescence intensity in each well of the plate [14] . Fluorescence data files from each plate were analyzed using the SDS 2.0 Allele Calling software (Applied Biosystems). Several data points (signal intensity) were eliminated to preserve the reliability of the assay system (missing data are guaranteed to be <1%).
Power calculation
The power calculation of this study was performed considering the multiple comparisons. For the SNPs with the minor allele frequency of >30% (all SNPs except rs1799742) and 16% (rs1799742), the power of this study were >90 and 75%, respectively, when the odds ratio (OR) was 1.5.
Statistical analyses
Data are expressed as mean AE SD except where otherwise indicated. Student's t-test was used to evaluate differences in means, and chi-square tests were used to evaluate differences in proportions. Some clinical and biochemical parameters were not normally distributed, and the nonparametric Mann-Whitney or Kruskal-Wallis tests were applied. To confirm Hardy-Weinberg equilibrium among the genotypes, the chi-square test was used (P ! 0.05). To reduce the risk of a false positive result due to multiple comparisons, we obtained the corrected P-value by Bonferroni's method and presented the nominal and the corrected P-values. Pair-wise interaction between the SNPs was assessed using logistic regression analysis. Significant differences were defined as P <0.05. All statistical analyses were performed using SPSS version 15.0.1J (SPSS Inc., Chicago, IL).
Results

Characteristics of the study population
The clinical characteristics of the 2927 subjects entered into the final analysis are shown in Table 1 . The mean age of the population was 63 years, with 1332 males (45.5%). There were 1602 subjects (54.7%) with hypertension, 230 (7.9%) with diabetes, 972 (33.2%) with hypercholesterolemia and 882 subjects (30.1%) were classified as obese.
Albuminuria was present in 563 subjects (19.2%). The subjects with albuminuria were older, and more likely to be female, have hypertension, diabetes, hypercholesterolemia, be obese and have a higher hsCRP, but were less likely to consume alcohol and be current smokers, compared to subjects with normoalbuminuria.
Selection of polymorphisms in proinflammatory cytokine genes
One SNP from each of six proinflammatory cytokine genes (IL-1b, IL-6, IL-8, TNF-a, CCL1 and MCP-1/CCL2) that displayed a minor allele frequency >0.1 in the Japanese population was selected for genotyping. The characteristics of these SNPs are summarized in Table 2 .
Association of single-point mutations in proinflammatory cytokine genes with albuminuria
Firstly, the association of SNPs in these proinflammatory cytokine genes with albuminuria was examined. As shown in Table 3 , specific genotypes of IL-6 and CCL1 were significantly associated with albuminuria (P ¼ 0.035 for IL-6 and P ¼ 0.007 for CCL1). After an adjustment for multiple comparisons by Bonferroni's method, the association with albuminuria remained significant in rs2289691 (P ¼ 0.048), but not in rs2069852 (P ¼ 0.221). A higher prevalence of albuminuria was observed in subjects with the A/ A 1 A/G genotype at rs2069852 in IL-6 and those with the A/A genotype at rs2282691 in CCL1 (A/A 1 A/G, 19.9% versus G/G 13.2% at rs2069852, P ¼ 0.01; A/A 23.3% versus T/T 1 T/A 17.8% at rs2282691, P ¼ 0.002).
Next, unadjusted and multivariate adjusted analyses were performed to determine whether these genotypes were independent predictive factors for albuminuria (Table 4 ). The unadjusted model showed that the A/A 1 A/G genotypes at rs2069852 in IL-6 and the A/A genotype at rs2282691 in CCL-1 were significantly associated with albuminuria [OR 1.623, 95% confidence interval (CI) 1.117-2.357, P ¼ 0.011 for rs2069852 A/A 1 A/G; OR 1.404, 95% CI 1.133-1.741, P ¼ 0.002 for rs2282691 A/A]. In the multivariate model, after adjustment for traditional risk factors, including gender, age, consumption of alcohol, smoking, obesity, diabetes, hypertension and hypercholesterolemia, these associations were still significant (OR 1.782, 95% CI 1.171-2.712, P ¼ 0.007 for rs2069852 A/ A 1 A/G; OR 1.432, 95% CI 1.128-1.770, P ¼ 0.003 for rs2282691 A/A). Logistic regression analysis revealed no significant interaction between the two SNPs (rs2282691 and rs2069852), suggesting the effect of the two SNPs is likely to be independent.
The additive effects of the high-risk genotypes on albuminuria
The additive effects of the combination of these genotypes in predicting albuminuria were also examined. In the multivariate model, the ORs for albuminuria were 1.644 (95% CI 1.012-2.669, P ¼ 0.045) with either high-risk genotype alone and 2.385 (95% CI 1.434-3.967, P ¼ 0.0008) with both high-risk genotypes, as compared with having neither high-risk genotype (Table 4 ). The trend of ORs was significant (P ¼ 0.0003). The prevalence of albuminuria and the UACR were also increased in subjects with an increased number of high-risk genotypes (Figure 1 ). The prevalence of albuminuria was 12.1, 18.2 and 24.3% These results indicated that the combination of these high-risk genotypes and alleles additively increased the risk of albuminuria, irrespective of serum hsCRP levels.
Discussion
In this study, the genotypes of the proinflammatory cytokines, IL-6 and CCL1 were associated with albuminuria and these polymorphisms had additive effects on the prevalence and severity of albuminuria in the general population. This indicated that in addition to environmental factors, genetic factors influencing the inflammatory response may play a role in the development of renal injury.
The association between renal injury and genetic factors has been extensively investigated in diabetic nephropathy, and several candidate genes, including the solute carrier In contrast, few studies have investigated the genetic factors associated with albuminuria in the general population. Previously, we reported that a SNP in the CCL5 promoter region was associated with the UACR levels in nondiabetic subjects [16] . However, in this study, the prevalence of albuminuria was not different between the CCL5 genotypes, suggesting that this polymorphism might not have a strong effect on the initiation of albuminuria. In contrast, the present study has shown that SNPs in the IL-6 and CCL1 genes were independently and additively associated with albuminuria in the general population. This finding suggested that genetic factors are implicated in the development of renal injury in the general population. Among the proinflammatory cytokines, IL-6 plays a key role in tissue injury by increasing the production of other chemotactic and proinflammatory molecules [17] . The association of IL-6 genotypes with renal injury in diabetic patients has been reported previously [7] . The findings from the present study in a general population are in keeping with the previous observation in diabetic patients, suggesting that IL-6 may be involved in a common pathway leading to renal disease.
On the other hand, the role of CCL1 in renal injury is largely unknown. CCL1 is secreted mainly by mononuclear phagocytes and is involved in innate and adaptive immunity through monocyte activation [18] . Although high concentrations of CCL1 have been detected in synovial fluid and macrophages of patients with juvenile idiopathic arthritis [18] , the association between CCL1 and renal disease has not been examined previously. The role of CCL1 in renal injury needs further investigation.
Of note, the present study showed that a combination of high-risk genotypes additively increased the risk of albuminuria. This suggests that genetic factors related to inflammation may have a cumulative effect on renal injury. A variety of cytokines are expressed by infiltrating inflammatory cells and Chr, chromosome; NCBI, National Center for Biotechnology Information; Allele 1 ¼ major allele; Allele 2 ¼ minor allele. The call rate for genotyping was >99%. All SNPs were in Hardy-Weinberg equilibrium (P > 0.1). resident renal cells [8] . Therefore, it is possible that a network of cytokines is formed and has mutually dependent effects on injured renal tissue. Interestingly, the serum hsCRP levels were not different between the combinations of these genotypes. This suggests that the genetic properties of these cytokines might affect the development of albuminuria by the modulation of not systemic, but local inflammatory response. In order to clarify the mechanisms involved, the interactions among IL-6, CCL1 and other cytokines in the kidney could be investigated in the future. The multiple comparisons have a higher risk of type I error, false-positive result. To avoid such an error, an adjustment by Bonferroni's method was performed in this study. After correction, the significant association with albuminuria was lost in rs2069852. However, the Bonferroni correction might be too conservative as an adjustment for multiple comparisons. The overcorrection and subsequent loss of power might prevent the detection of a weak, but significant relation between the SNPs and albuminuria.
The prevalence of albuminuria (19.2%) in this study seems to be higher than those in European and American population (7-8.3%) [19, 20] . However, this value is within the range of previous reports conducted in general Japan population (13.2-19.6%) [21, 22] . Another study documented that the incidence of microalbuminuria (40%) in hypertensive diabetic patients is higher in Asia than in North America and Europe (16-29%) [23] . Therefore, an Asian population including Japanese might be susceptible to albuminuria when compared with other populations. In addition, several factors including differences in the method of collecting urinary samples and characters of subjects might cause the difference in part.
There were several limitations to this study. First, the results suggest a possible link between IL-6 and CCL1 genotypes and albuminuria; however, the cross-sectional nature of this study does not allow an inference of causality. Follow-up studies are required to examine the causality of these associations. Second, serum or urinary levels of these proinflammatory cytokine proteins were not investigated in this study. Therefore, it is not possible to speculate on the detailed mechanism by which polymorphisms in these cytokine genes may affect the inflammatory response and renal injury. Third, the UACR was assessed on a single occasion. Transient increases in the UACR may have distorted the relationship between UACR and these genotypes, leading to underestimation of the effect of high-risk genotypes on albuminuria. Fourth, although it is important to validate our findings in independent patient collections, this study does not include the replication analysis. The researches on the genetic property of albuminuria have been conducted mainly in Europe and North America; however, the rs2069852 in IL-6 is almost monomorphic (G/G) in the population of European and African origin, according to the observation in International HapMap Project. Furthermore, there has been no report typing the relevant SNPs of CCL1 (rs2282691) except our cohort. Therefore, at present moment, it is very difficult to find another cohort large enough to replicate our results. Currently, we are recruiting another cohort in Japan to explore the genetic background of common diseases. It could be used for this purpose in future. Fifth, we selected one common SNP in each gene, based on previous reports. Because our knowledge of the regulation and the function of the targeted genes is incomplete, this approach may fail to discover important, novel SNPs that are related to albuminuria. In addition, although the common SNPs is the major source of genetic variation in the candidate genes, it remains possible that rare variants or the structural alterations including copy number variants and inversions can have large effects on the development of albuminuria.
In conclusion, this study showed that certain proinflammatory cytokine genotypes were associated with an increased risk of albuminuria in the general population. The detection of subjects with high-risk genotypes may help in the prevention of subsequent renal and cardiovascular events.
